Oligonucleotide microarray analysis of estrogen receptor α-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen
Sengül Tozlu-Kara(Lyon 1 Université), Ivan Bièche(Centre National de la Recherche Scientifique), M. Tubiana-Hulin(Heidelberg University), Julie A. Vendrell(Inserm), Philippe Dessen(Centre National de la Recherche Scientifique), V. Roux(Lyon 1 Université), Charlotte Andrieu‐Soler(Délégation Paris 5), Pascale A. Cohen(Lyon 1 Université), Sophie Vacher(Université Paris Sciences et Lettres), Rosette Lidereau(Inserm), F. Spyratos(Inserm), Vladimir Lazar(Institut Gustave Roussy)
Cited by 33
Related Papers
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
|Cancer Discovery|2017|781
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
|Journal of Clinical Oncology|2015|497
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
|JNCI Journal of the National Cancer Institute|2006|480